Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration

Experimental Hematology

Volumn 38, Issue 11, 2010, Pages 1115-1123

  van Os, Ronald ^a   Ausema, Albertina ^a   Dontje, Bert ^a   van Riezen, Manon ^a   van Dam, Gooitzen ^a   de Haan, Gerald ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLUMINESCENCE; BONE MARROW; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; DONOR; ENGRAFTMENT; FEMUR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT;

ANIMALS; BONE MARROW; BONE MARROW CELLS; FEMALE; FEMUR; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; INJECTIONS, INTRAVENOUS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, ISOGENEIC; WHOLE-BODY IRRADIATION;

ANIMALIA; MURINAE;

EID: 78649355196     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.07.003     Document Type: Article

References (35)

1. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901-1910.
2. Williams D.A., Rios M., Stephens C., Patel V.P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 1991, 352:438-441.
3. van der Loo J.C., Xiao X., McMillin D., Hashino K., Kato I., Williams D.A. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest 1998, 102:1051-1061.
4. Wierenga P.K., Weersing E., Dontje B., de Haan G., van Os R. Differential role for very late antigen-5 in mobilization and homing of hematopoietic stem cells. Bone Marrow Transplant 2006, 38:789-797.
5. Khaldoyanidi S., Denzel A., Zoller M. Requirement for CD44 in proliferation and homing of hematopoietic precursor cells. J Leukocyte Biol 1996, 60:579-592.
6. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., Scott L.M. Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2)-integrins and selectins. Blood 2001, 98:2403-2411.
7. Avigdor A., Goichberg P., Shivtiel S., et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
8. Kollet O., Spiegel A., Peled A., et al. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 2001, 97:3283-3291.
9. Lapidot T., Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002, 16:1992-2003.
10. Ma Q., Jones D., Springer T.A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999, 10:463-471.
11. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
12. Jung Y., Wang J., Schneider A., et al. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006, 38:497-508.
13. Ponomaryov T., Peled A., Petit I., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000, 106:1331-1339.
14. Hendrikx P.J., Martens C.M., Hagenbeek A., Keij J.F., Visser J.W. Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol 1996, 24:129-140.
15. Orschell-Traycoff C.M., Hiatt K., Dagher R.N., Rice S., Yoder M.C., Srour E.F. Homing and engraftment potential of sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000, 96:1380-1387.
16. Szilvassy S.J., Meyerrose T.E., Ragland P.L., Grimes B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 2001, 98:2108-2115.
17. Van Hennik P.B., de Koning A.E., Ploemacher R.E. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999, 94:3055-3061.
18. Matsuzaki Y., Kinjo K., Mulligan R.C., Okano H. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 2004, 20:87-93.
19. Camargo F.D., Chambers S.M., Drew E., McNagny K.M., Goodell M.A. Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 2006, 107:501-507.
20. Kushida T., Inaba M., Takeuchi K., Sugiura K., Ogawa R., Ikehara S. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation. Blood 2000, 95:1862-1868.
21. Mazurier F., Doedens M., Gan O.I., Dick J.E. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003, 9:959-963.
22. McKenzie J.L., Gan O.I., Doedens M., Dick J.E. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 2005, 106:1259-1261.
23. Li Q., Hisha H., Yasumizu R., et al. Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes. Stem Cells 2007, 25:1186-1194.
24. Shi M., Adachi Y., Shigematsu A., et al. Intra-bone marrow injection of donor bone marrow cells suspended in collagen gel retains injected cells in bone marrow, resulting in rapid hemopoietic recovery in mice. Stem Cells 2008, 26:2211-2216.
25. Omae M., Inaba M., Sakaguchi Y., et al. Long-term maintenance of donor-derived hematopoiesis by intra-bone marrow-bone marrow transplantation. Stem Cells Dev 2008, 17:291-302.
26. Sweeney T.J., Mailander V., Tucker A.A., et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 1999, 96:12044-12049.
27. Waterstrat A., Liang Y., Swiderski C.F., Shelton B.J., Van Z.G. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood 2010, 115:408-417.
28. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 2009, 43:935-940.
29. Aiuti A., Tavian M., Cipponi A., et al. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol 1999, 29:1823-1831.
30. Kawabata K., Ujikawa M., Egawa T., et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci U S A 1999, 96:5663-5667.
31. Jo D.Y., Rafii S., Hamada T., Moore M.A. Chemotaxis of primitive hematopoietic cells in response to stromal cell- derived factor-1. J Clin Invest 2000, 105:101-111.
32. Peled A., Kollet O., Ponomaryov T., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000, 95:3289-3296.
33. Verfaillie C.M., Benis A., Iida J., McGlave P.B., McCarthy J.B. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the adhesion receptor. Blood 1994, 84:1802-1811.
34. Wang J., Kimura T., Asada R., et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 2003, 101:2924-2931.
35. - sorted cells harbor intracellular CXCR4, which can functionally be expressed and provide NOD/SCID repopulation. Blood 2002, 100:2778-2786.